T Walley. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug Prescriptions/economicsDrug Therapy/economicsGovernment AgenciesHumansNational Health Programs/legislation & jurisprudenceUnited Kingdom
Year: 1995 PMID: 10155332 DOI: 10.2165/00019053-199507060-00001
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981